Clinical Trials
14
Active:0
Completed:4
Trial Phases
3 Phases
Phase 3:2
Phase 4:2
Not Applicable:5
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (9 trials with phase data)• Click on a phase to view related trials
Not Applicable
5 (55.6%)Phase 3
2 (22.2%)Phase 4
2 (22.2%)No trials found
News
Polatuzumab Offers New Hope for Diffuse Large B-Cell Lymphoma Treatment in India
Polatuzumab, a first-in-class anti-CD79b antibody-drug conjugate, has been approved in India for first-line treatment of Diffuse Large B-Cell Lymphoma (DLBCL).